RR
Robert W. Ross
Chief Executive OfficerDirector

Robert W. Ross insider trades: Surface Oncology (SURF) stock sales

Chief Executive Officer, Surface Oncology Last trade Aug 1, 2023 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2020
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 1, 2023SURF↓ Sell$16K
Aug 3, 2022SURF↓ Sell$18K
Jul 21, 2021SURF↓ Sell$204K
Feb 16, 2021SURF↓ Sell$11K
Jan 15, 2021SURF↓ Sell$108K
Dec 15, 2020SURF↓ Sell$10K
Dec 11, 2020SURF↓ Sell$14K
Nov 11, 2020SURF↓ Sell$6K
Oct 14, 2020SURF↓ Sell$40K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert W. Ross's insider trades

Robert W. Ross is Chief Executive Officer at Surface Oncology (SURF). Since Oct 14, 2020, Robert has reported no open-market purchases and 9 sales worth $429K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SURF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.